Physician profile
Imad E Khadra
NPI 1205855418
$4,071.96
in general payments reported to CMS, 2019-2025
15 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.18 · 2020: $41.85 · 2021: $50.61 · 2023: $422 · 2024: $3,328 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,347 · Travel and Lodging: $355 · Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,346.95 |
| Travel and Lodging | $354.96 |
| Food and Beverage | $182.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,693.20 | 2023-2024 | Da Vinci Surgical System |
| Mallinckrodt Hospital Products INC. | $82.55 | 2025 | Terlivaz |
| Olympus America INC. | $49.97 | 2023 | Spin Vision Scope, 4.0mm Od, 2.0mm Wc, Spiration Valve System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.02 | 2021-2025 | Jascayd |
| Glaxosmithkline, LLC. | $38.32 | 2019-2020 | |
| Olympus Corporation of The Americas | $25.76 | 2019 | |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Zerbaxa |
| Resmed Corp | $18.29 | 2020 | |
| United Therapeutics Corporation | $17.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.72 | 2019 | |
| Pulmonx Corporation | $16.68 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.76 | 2019 | |
| Boston Scientific Corporation | $11.62 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.56 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.94 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imad Khadra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.